SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-22-218665
Filing Date
2022-08-11
Accepted
2022-08-11 17:00:03
Documents
3
Group Members
ABINGWORTH BIOVENTURES 8 LPABINGWORTH LLPCARLYLE GENESIS UK LLCCARLYLE HOLDINGS I GP INC.CARLYLE HOLDINGS I GP SUB L.L.C.CARLYLE HOLDINGS I L.P.CARLYLE INVESTMENT MANAGEMENT L.L.C.CG SUBSIDIARY HOLDINGS L.L.C.TC GROUP, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d392800dsc13da.htm SC 13D/A 202174
2 EX-99.1 d392800dex991.htm EX-99.1 13524
3 EX-99.2 d392800dex992.htm EX-99.2 11640
  Complete submission text file 0001193125-22-218665.txt   229521
Mailing Address C/O THE CARLYLE GROUP 1001 PENNSYLVANIA AVENUE, N.W. WASHINGTON DC 20004
Business Address C/O THE CARLYLE GROUP 1001 PENNSYLVANIA AVENUE, N.W. WASHINGTON DC 20004 202 729 5626
Carlyle Group Inc. (Filed by) CIK: 0001527166 (see all company filings)

IRS No.: 452832612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6282 Investment Advice

Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Subject) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90283 | Film No.: 221156758
SIC: 2834 Pharmaceutical Preparations